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Background: Community-acquired pneumonia (CAP) is a common cause of morbidity and 
mortality in older adults. Although diabetes mellitus is a risk factor for pneumonia, the clinical 
impact of blood glucose level at the time of admission is not clear. Our goal was to examine 
the association between admission hyperglycemia and subsequent mortality, length of stay, and 
readmission outcomes in older adults with CAP.
Methods: A retrospective observational study was conducted using hospital data for community-
acquired pneumonia admissions in 857 persons from January 1, 2008 to December 31, 2010. 
We examined the effects of admission glucose level on mortality, length of stay, and 30 day 
readmission, adjusted for demographic factors and comorbidity.
Results: The mean age of the sample was 64 years, and 51% of the subjects were female. 
Inpatient mortality occurred in 4.6% and the median length of stay was 5 days (interquartile range 
3–9 days). Readmission within 30 days occurred in 17%. We found little impact of first glucose 
measures on in-hospital mortality (P = 0.94), length of stay (P = 0.95), and 30-day readmission 
(P = 0.56). Subjects 65 years and older trended towards higher in-hospital mortality. Older age, 
cancer, heart failure, and cirrhosis were associated with adverse outcomes.
Conclusion: Glucose level upon admission for community-acquired pneumonia was not 
associated with adverse outcomes within 30 days in older adults.
Keywords: community-acquired pneumonia, hyperglycemia, readmission rates, hospital 
mortality
Introduction
Pneumonia is the eighth most common cause of death in the USA and ranks second 
among infectious causes of mortality.1,2 Over five million people develop pneumonia every 
year in the US, mostly older adults.3 Diabetes mellitus is a risk factor for pneumonia, 
and as many as one-quarter of persons with community-acquired pneumonia (CAP) are 
diabetic.3,4 Hyperglycemia has been established as an independent predictor of morbidity 
and mortality in patients admitted with acute coronary syndromes, ischemic stroke, 
trauma, heart failure, and coronary artery bypass graft (CABG), as well as admission to 
surgical and medical intensive care units.5,6 Although hyperglycemia leads to impaired 
host immune responses, the impact of hyperglycemia on concrete clinical outcomes (eg, 
mortality, length of stay, and readmission) is not clear in CAP. Data on hyperglycemia 
and CAP are limited. The existing relevant literature shows mixed results, with most 
studies focused on hospital complications associated with hyperglycemia.4–8
Glycemic status at admission is readily available for all patients, and might provide a 
potentially useful predictive factor for outcomes and utilization of care. Our goal was to 
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examine potential associations of admission hyperglycemia 
with mortality, length of stay, and readmission rates in 
patients with CAP.
Methods
Cohort and measures
Retrospective observational data were extracted from 
admissions to the University of Kansas Medical Center for 
community-acquired pneumonia (ICD-9-CM code 480–487) 
from January 1, 2008 through December 31, 2010. Only 
persons aged 40 years and older were sampled. Our analysis 
examines the effects of first glucose measure upon admission 
and age on hospital mortality, length of stay (LoS), and 
readmission for community-acquired pneumonia (CAP) 
within 30 days. Data for a total of 1012 CAP admissions were 
provided. In addition to the primary explanatory measures, 
demographics (sex and race/ethnicity [American Indian/
Eskimo/Aleutian, black, Hispanic, Oriental/Asian/Pacific 
Islander/Indonesian, white, or other]) were also analyzed. 
Medical comorbidities, including the presence or absence of 
cancer, chronic heart failure, chronic renal failure, cirrhosis, 
HIV, and diabetes were provided in the hospital discharge 
data. We assigned the patients to three groups. Glucose was 
categorized as normal glycemia (,126), mild hyperglycemia 
(126–,180), and uncontrolled hyperglycemia ($180).
Statistical analysis
Univariate descriptive statistics (mean, standard deviation, 
and percentiles for continuous measures and frequencies 
and relative frequencies for categorical measures) were 
derived. Bivariate analyses were also conducted by generating 
contingency tables with glucose (,126/126 to ,180/$180), 
and Pearson’s Chi-square test or exact test alternatives 
were conducted. Descriptive statistics for age within glucose 
levels were also generated, and age distributions across these 
groups was performed using one-way analysis of variance. 
Comparisons of LoS between strata were performed using 
the log-rank test. Unconditional logistic regression was used to 
model in-hospital mortality and 30-day hospital readmission 
as a function of glucose and age, adjusted for other potential 
confounding variables such as sex, race/ethnicity, and 
comorbid conditions. (Diabetes was not included as a covariate 
due to its strong association with the explanatory measure of 
interest: glucose.) Models were built using stepwise selection 
with an entry criterion of a score test P-value less than 0.15 
and a retaining criteria of P , 0.10 from the Wald test. An 
interaction term between glucose and age group was also 
evaluated in a model that was adjusted for the other covariates 
selected from this model building process. These enabled the 
assessment of whether the effects of glucose on mortality and 
on readmission were different among those ages 65 and older 
compared to those ages 40–64. The final models were assessed 
using the Hosmer–Lemeshow goodness-of-fit test. Adjusted 
odds ratios and corresponding 95% Wald confidence intervals 
(CI) were generated. Cox proportional hazards regression was 
used to model LoS as a function of glucose and age, adjusted 
for other potential confounding variables such as sex, race/
ethnicity, and comorbid conditions. Subjects who died; were 
discharged to hospice; transferred to another institution; or 
left against medical advice, were treated as right-censored 
observations for this analysis. A model was built using the 
same stepwise procedure as described above for the logistic 
regression models, and analogous testing for an interaction 
effect between glucose category and age group was conducted. 
Adjusted hazard ratios and corresponding 95% Wald CI were 
generated.
All data management and data analysis were performed 
using SAS version 9.2 (2002–2008, SAS Institute Inc, Cary, 
NC, USA).
Results
One thousand and twelve community-acquired pneumonia 
admissions were identified. Missing data required exclusion 
of 21 records (one hospitalization was missing a valid 
code for disposition; three records were missing data for 
the race variable; and 17 were missing a glucose measure 
for the corresponding admission). After these exclusions, 
991 hospitalization records remained which were generated 
by 857 unique subjects because of repeated hospitalizations 
in some individuals. Each of these was allowed to contribute 
only one hospitalization to the analysis. Thus, these 
857 subjects comprised the sample for the mortality and 
length of stay outcome measures (Table 1). However, for the 
analysis of readmission rates, we further excluded those who 
died in the hospital or were discharged to hospice, leaving a 
final sample of 797 persons (Table 2).
The mean age of the sample was 64 years, and 51% were 
female. Over 70% of the population was non-Hispanic white. 
Comorbidities are shown in Table 1. Glucose was categorized 
as normoglycemia in 58.1%, mild hyperglycemia in 27.8%, 
and uncontrolled hyperglycemia in 14%. Twenty-nine 
percent had a recognized diagnosis of diabetes mellitus; 
this diagnosis was associated with higher glucose levels 
(P , 0.001).
In Table 1, inpatient mortality occurred in 4.6%. 
The median length of stay was 5 days, (inter-quartile 
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Table 1 Baseline characteristics of all the patients admitted for pneumonia
All subjects** Normal Mild 
hyperglycemia
Uncontrolled 
hyperglycemia
P-value****
,126 mg/dl 126–,180 mg/dl $180 mg/dl
Total 857 498 238 121
Age
 Years* 64.1 ± 13.3 63.3 ± 13.7 65.4 ± 13.0 64.8 ± 12.2 0.121
 65+ 401 (46.8) 227 (45.6) 115 (48.3) 59 (48.8) 0.703
Male 416 (48.5) 234 (47.0) 122 (51.3) 60 (49.6) 0.538
heart failure 183 (21.4) 90 (18.1) 61 (25.6) 32 (26.5) 0.022
Cirrhosis 22 (2.57) 14 (2.81) 3 (1.26) 5 (4.13) 0.231
Chronic renal failure 161 (18.8) 83 (16.7) 50 (21.0) 28 (23.1) 0.154
hIV 4 (0.47) 4 (0.80) 0 0 0.279
Cancer 226 (26.4) 150 (30.1) 58 (24.4) 18 (14.9) 0.002
Diabetes 250 (29.2) 89 (17.9) 70 (29.4) 91 (75.2) ,0.0001
Mortality 39 (4.55) 24 (4.82) 10 (4.20) 5 (4.13) 0.906
Length of stay*** 5.0 (3.0, 9.0) 5.0 (3.0, 9.0) 5.0 (3.0, 9.0) 5 (3.0, 10.0) 0.736
Notes: *Mean ± std; **n (%); ***median (25th percentile, 75th percentile); ****P-values are from Pearson’s Chi-square test for categorical measures with the exception of 
hIV (which used the alternative exact test) and analysis of variance for age (continuous).
Table 2 Baseline characteristics of patients admitted for pneumonia and discharged from the hospital
Subjects in 30-day 
readmission
Normal Mild 
hyperglycemia
Uncontrolled 
hyperglycemia
P-value***
,126 mg/dl 126–,180 mg/dl $180 mg/dl
Total 797 466 219 112
Age
 Years* 63.8 ± 13.4 63.0 ± 13.8 64.8 ± 12.8 64.8 ± 12.3 0.201
 65+** 363 (45.6) 208 (44.6) 102 (46.6) 53 (47.3) 0.822
Male** 387 (48.6) 217 (46.6) 112 (51.1) 58 (51.8) 0.408
heart failure** 164 (20.6) 81 (17.4) 55 (25.1) 28 (25.0) 0.03
Cirrhosis** 18 (2.26) 10 (2.15) 3 (1.37) 5 (4.46) 0.163
Chronic renal failure** 147 (18.4) 77 (16.5) 45 (20.6) 25 (22.3) 0.234
hIV** 4 (0.5) 4 (0.86) 0 0 0.279
Cancer** 193 (24.2) 132 (28.3) 46 (21.0) 15 (13.4) 0.002
Diabetes** 232 (29.1) 82 (17.6) 64 (29.2) 86 (76.8) ,0.0001
30 day readmission rate** 137 (17.2) 78 (16.7) 36 (16.4) 23 (20.5) 0.596
Notes: *Mean ± std; **n (%); ***P-values are from Pearson’s Chi-square test for categorical measures (with the exceptions of cirrhosis and hIV, which used the alternative 
exact tests) and analysis of variance for age (continuous).
range 3–9 days). Readmission within 30 days occurred in 17% 
(Table 2). None of these clinical outcomes differed by glucose 
category. The length of stay, readmission rate, and inpatient 
mortality were similar in the three glucose categories.
Multivariable models were built that forced glucose and 
age group into the model. Covariates included in the model 
for length of stay were cancer, chronic renal failure, and 
cirrhosis. Hazard ratios (HRs) for LoS indicated essentially 
no effect of glucose (HR: 1.03, 95% CI: 0.86–1.23 for 
126–,180 versus , 126; HR: 0.99, 95% CI: 0.79–1.25 
for $180 versus , 126) and shorter LoS among those ages 
40–64 (versus 65 and older; HR: 1.23; 95% CI: 1.04–1.44). 
The P-values for these two factors were 0.95 and 0.01 for 
glucose and age group, respectively. Thus, age group described 
significant variation in the hospital LoS, but glucose did not 
in this cohort. Controlling for age, no differences in the risk 
of 30-day readmission between the various levels of glucose 
were detected (P = 0.56). Controlling for age, no differences 
in the risk of in-hospital mortality between the various levels 
of glucose were detected (P = 0.94). This suggested that 
no effect for glucose (consistent with the bivariate results) 
and no interaction effect for glucose with age on length of 
stay (P = 0.20), 30-day readmission (P = 0.50), or mortality 
(P = 0.91) were detected.
Discussion
This retrospective observational study of CAP admission data 
revealed that the first glucose measure upon admission did 
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not predict hospital mortality, length of stay, or readmission 
for community-acquired pneumonia within 30 days in the 
University of Kansas Medical Center in the USA.
However, there are several limitations to consider. We 
were not able to follow these patients after discharge from the 
hospital except to observe readmissions to the same hospital. 
Mortality during the hospital stay was uncommon, and we 
were unable to capture post-discharge mortality. Thus, this 
study sample may be too small to capture possible differences 
in longer term mortality outcomes across different levels of 
admission glucose. We were not able to examine changes in 
serum glucose throughout the hospital stay. There was no 
structured protocol in treatment for patients with increase 
serum glucose, which was instead left to the discretion of 
the health care providers within our center. A single measure 
of hyperglycemia at admission might reflect the production 
of stress related counter-regulatory hormones due to acute 
illness. We are unable to exclude the possibility that severity 
of illness was differentially distributed across levels of glucose 
control. This question should be tested in a larger study sample 
in which measures of severity of illness are available.
A US study reported by Labraere et al6 reached similar 
conclusions to our own. In contrast, our findings differ 
from a recently published German prospective study by 
Lepper et al7 showing that serum glucose at the time of 
hospital admission for community-acquired pneumonia 
(n = 6870) was a predictor of death at 90 days after admission. 
This prospective study had a longer follow up time period, 
and captured specific patient-level clinical factors such as 
confusion, respiratory rate, and blood pressure. Our study 
population was demographically different and had a three-
fold higher rate of malignancy than that in Lepper’s trial.7 
The underlying difference in study population may account 
in part for disparate conclusions.
Conclusion
Our retrospective observational study of community-acquired 
pneumonia admission data revealed that f irst glucose 
measure upon admission did not predict hospital mortality, 
length of stay, or readmission for community-acquired 
pneumonia within 30 days. Further research on the impact 
of hyperglycemia needs to be done in larger, diverse samples 
of CAP patients.
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